Knee Reconstruction Devices Market Outlook (2023 to 2033)

The global knee reconstruction devices market is expected to reach a market valuation of US$ 8.5 billion by 2023, accelerating with a moderate CAGR of 4.3% from 2023 to 2033. The knee reconstruction devices market is anticipated to be valued at about US$ 13.0 billion by 2033 end.

According to FMI's analysis, the global knee reconstruction devices market has been expanding rapidly due to product design and functionality innovations. The knee reconstruction devices market participants have benefited from the prevalence of ailments like arthritis and knee discomfort. Furthermore, critical regulatory authorities worldwide have relaxed authorizations to provide better market access.

Innovative and effective knee repair methods and gadgets have been made possible by the rapid development of healthcare technology in recent years. Market shifts are also being driven by rising demand for minimally invasive procedures. Surgical procedure and instrument advancements have had a major impact on the current knee reconstruction devices industry.

The demand for knee reconstruction devices is expected to rise because of technological improvements and the rising prevalence of orthopedic disorders leading to an increase in surgeries. The expanding patient pool and increased prevalence of lifestyle-related illnesses are also contributing to the knee reconstruction devices market's expansion. It has been determined that the reconstruction of the hip or knee is not an emergency during the current COVID-19 pandemic.

As the number of companies producing knee reconstructive devices continues to grow, competition in the industry is heating up. Companies also plan to pour resources into R&D for new and improved products to remain competitive. The knee reconstruction devices industry is making larger bets on emerging technologies like 3D printing.

The newest innovations are more cost-effective and take advantage of mobile apps that help doctors keep tabs on evolving data in real time and provide improved patient care. All these advantages are expected to increase demand for knee reconstruction devices, driving the market forward during the forecasted time frame. Growth in the knee reconstruction devices market is predicted to be aided by the increased availability of newer, more advanced equipment for both healthcare providers and their patients.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Knee Reconstruction Devices Market: What's Driving It, and What's Holding It Back

Reduced surgical time is a direct outcome of the increased precision and accuracy made possible by minimally invasive approaches to knee reconstruction. Modern surgical techniques have bolstered demand for knee reconstruction devices, greatly reducing the complications plaguing older procedures. It is a major component fuelling the worldwide market expansion for knee reconstruction devices.

To increase performance with fewer incisions and complications, knee reconstruction surgery is receiving more funding for research and development. Trust in the gadgets and treatments is boosted by the availability of such items, which is expected to fuel knee reconstruction devices market expansion in the upcoming years. Increases in knee injuries and the need for reconstruction drive growth in the global knee reconstruction devices market.

Meanwhile, government investments in healthcare infrastructure have helped knee reconstructive technologies gain significant traction in healthcare systems worldwide. However, producers confront many hurdles that could ultimately slow the knee reconstruction devices industry's progress over the long run.

Knee reconstructive devices are prohibitively expensive, which slows their widespread use. Knee replacement and reconstruction tools competition in the market is hampered by the need to comply with increasingly stringent rules established by agencies like the Food and Drug Administration. In addition, postoperative complications, particularly those related to biocompatibility, will likely continue to worry market participants for the foreseeable future.

Attributes Details
Market CAGR (2023 to 2033) 4.3%
Market Valuation (2023) US$ 8.5 billion
Market Valuation (2033) US$ 13.0 billion

Country-Wise Analysis of the Knee Reconstruction Devices Market

Countries Forecast Period Share Between 2023 to 2033
United States 29.5%
Germany 8.1%
Japan 5.0%
Countries Forecast Period CAGR Between 2023 to 2033
Australia 4.4%
China 4.0%
India 3.8%
United Kingdom 3.4%

Performance of the United States Market:

  • In recent years, hip and knee joint reconstruction surgeries have risen in the United States. Over a million hip and knee replacements are performed annually in the United States.
  • About half of American individuals are likely to develop knee osteoarthritis in their lifetimes. By 2033, there are expected to be 3.5 million knee replacement surgeries, a 670 percent increase from today.
  • Knee reconstruction devices treat musculoskeletal pain. Major manufacturers' continuous presence in the country should boost long-term growth.
  • The United States is estimated to secure a share of 29.5% in the global market by 2033.

How China Market is Upsurging?

  • The Chinese Medical Journal claims that up to 95% of all prosthetic joints sold in the United States are made in China. Unicondylar knee arthroplasty (UKA) and total knee arthroplasty (TKA) procedures both had significant increases in demand between 2011 and 2019 (up 600% and 100%, respectively).
  • Forecasts indicate that increased treatment options are likely to be utilized as disposable incomes and standards of life in China continue to rise. Investments in joint reconstructive products by Chinese pharmaceutical firms are expected to increase regional sales opportunities in East Asia and establish long-term growth forecasts.
  • China is anticipated to capture a CAGR of 4% in the global market by 2033.

Overview of the South African Market:

  • Revenue-wise, the South African knee reconstruction devices market brought in about 28.0% of the total in 2020. Adults over 65 in South Africa have a prevalence of osteoarthritis anywhere from 29.5% to 82.7% in rural areas and 55.1% in urban areas. The high rate of osteoarthritis in the country is expected to be a significant factor in the knee reconstruction devices market expanding throughout the anticipated time frame.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Competitive Landscape for the Knee Reconstruction Devices Market

There is a moderate market concentration in the knee reconstruction devices industry worldwide, with a few companies expected to account for most sales. Market leaders are putting more resources into Research and Development to create innovative products and gain approval from regulators more quickly to increase their knee reconstruction devices' market share.

Recent Developments

As part of their work on a digital surgery platform that uses linked technologies, Johnson & Johnson Medical Devices Company (J&JMD) announced in January 2021 that the FDA had granted permission for their VELYS Robotic-assisted solution for use with their Attune Total Knee System.

Active Technologies received FDA clearance in March 2021 for its Citrespline and Citrelock ligament reconstruction devices, intended to prevent soft tissue damage during insertion. These devices can be used for reconstructive procedures on various joints, including the knee.

Furthermore, Conformis Inc. stated that its patient-specific iTotal PS total knee replacement system had been approved by the Therapeutic Goods Administration in Australia. This technology is intended to provide patients with reconstructive processes unique to their bodies.

The Next Generation Of Joint Replacement Safety

Joint replacement surgeries are now safer and last longer than ever before because of the widespread adoption of 3D printing.

Greater than a million people in the United States alone have total joint replacements done each year. The aging of the population and the subsequent decrease in the average age at which these procedures are performed contribute to this rising trend. By the year 2030, it is expected that four million Americans are expected to have joint replacement surgery yearly.

Replacement of a damaged joint is the best option for people with advanced arthritis in terms of both cost and clinical outcomes, but it is not without its drawbacks. Whether or not a patient experiences any post-operative joint pain, how well the replacement common functions, and how long it lasts can all be affected by seemingly minor differences in implant placement and fit.

Computer modeling software and 3D printing are being used for the first time by surgeons in Yale's Department of Orthopaedics and Rehabilitation to better prepare for and carry out joint replacements. The devices help older people recover more quickly and safely and improve outcomes.

As the technology progresses, global knee reconstruction devices market players are adopting new trends to change the outlook.

A novel AI-based solution for 3D Reconstruction of knees from X-ray images was recently announced by RSIP Vision, a developer of AI and computer vision technologies. This technology offers doctors an in-depth 3D model of each bone, which can be used for pre-operative planning and implant sizing.

It is expected to streamline doctors' procedures and reduce unnecessary expenses and radiation exposure. The doctors are likely to have a highly accurate 3D anatomical model of the patient's knee for pre-operative planning and customizing the implant.

Scope of Report

Attributes Details
Forecast Period 2023 to 2033
Historical Data Available for 2018 to 2022
Market Analysis US$ billion for Value
Key Countries Covered United States, United Kingdom, Japan, India, China, Australia, Germany
Key Segments Covered Product Type, End User, Indication, Region
Key Companies Profiled Zimmer, Inc.; Stryker Corporation; DePuy Synthes; Smith & Nephew; Corin; United Orthopedic Corporation; Arthrex Inc.; Exactech Inc.; DJO Global; Japan Medical Dynamic Marketing; Tornier Inc.
Report Coverage Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing Available upon Request

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Knee Reconstruction Devices Market by Segmentation

By Product:

  • Cemented Implants
  • Cementless Implants
  • Partial Implants
  • Revision Implants

By End User:

  • Hospitals
  • Orthopedic Clinics
  • ASCs

By Indication:

  • Osteoarthritis
  • Rheumatoid Arthritis
  • Trauma
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa (MEA)

Frequently Asked Questions

What is the Growth Potential of the Market?

The growth potential of the market is 4.3% through 2033.

Which Country Holds High Lucrativeness?

The United States is projected to emerge as a lucrative market.

What hampers the market?

The need to comply with increasingly stringent rules hampers the market.

What is China’s Expected Share by 2033?

China's market is projected to expand at 4% CAGR by 2033.

What Drives Sales in the Market?

Reduced surgical time is a direct outcome of the increased precision driving sales in the market.

Table of Content
1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Technology Roadmap Analysis
    1.5. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Product Life Cycle Analysis
    3.5. Supply Chain Analysis
        3.5.1. Supply Side Participants and their Roles
            3.5.1.1. Producers
            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
            3.5.1.3. Wholesalers and Distributors
        3.5.2. Value Added and Value Created at Node in the Supply Chain
        3.5.3. List of Raw Material Suppliers
        3.5.4. List of Existing and Potential Buyer’s
    3.6. Investment Feasibility Matrix
    3.7. Value Chain Analysis
        3.7.1. Profit Margin Analysis
        3.7.2. Wholesalers and Distributors
        3.7.3. Retailers
    3.8. PESTLE and Porter’s Analysis
    3.9. Regulatory Landscape
        3.9.1. By Key Regions
        3.9.2. By Key Countries
    3.10. Regional Parent Market Outlook
    3.11. Production and Consumption Statistics
    3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2018 to 2022
    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033
        5.3.1. Cemented Implants
        5.3.2. Cementless Implants
        5.3.3. Partial Implants
        5.3.4. Revision Implants
    5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022
    5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
    6.1. Introduction / Key Findings
    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022
    6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033
        6.3.1. Hospitals
        6.3.2. Orthopedic Clinics
        6.3.3. ASCs
    6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
    6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
    7.1. Introduction / Key Findings
    7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Indication, 2018 to 2022
    7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Indication, 2023 to 2033
        7.3.1. Osteoarthritis
        7.3.2. Rheumatoid Arthritis
        7.3.3. Trauma
        7.3.4. Others
    7.4. Y-o-Y Growth Trend Analysis By Indication, 2018 to 2022
    7.5. Absolute $ Opportunity Analysis By Indication, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
    8.1. Introduction
    8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
    8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
        8.3.1. North America
        8.3.2. Latin America
        8.3.3. Western Europe
        8.3.4. Eastern Europe
        8.3.5. South Asia and Pacific
        8.3.6. East Asia
        8.3.7. Middle East and Africa
    8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        9.2.1. By Country
            9.2.1.1. U.S.
            9.2.1.2. Canada
        9.2.2. By Product
        9.2.3. By End User
        9.2.4. By Indication
    9.3. Market Attractiveness Analysis
        9.3.1. By Country
        9.3.2. By Product
        9.3.3. By End User
        9.3.4. By Indication
    9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        10.2.1. By Country
            10.2.1.1. Brazil
            10.2.1.2. Mexico
            10.2.1.3. Rest of Latin America
        10.2.2. By Product
        10.2.3. By End User
        10.2.4. By Indication
    10.3. Market Attractiveness Analysis
        10.3.1. By Country
        10.3.2. By Product
        10.3.3. By End User
        10.3.4. By Indication
    10.4. Key Takeaways
11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        11.2.1. By Country
            11.2.1.1. Germany
            11.2.1.2. U.K.
            11.2.1.3. France
            11.2.1.4. Spain
            11.2.1.5. Italy
            11.2.1.6. Rest of Western Europe
        11.2.2. By Product
        11.2.3. By End User
        11.2.4. By Indication
    11.3. Market Attractiveness Analysis
        11.3.1. By Country
        11.3.2. By Product
        11.3.3. By End User
        11.3.4. By Indication
    11.4. Key Takeaways
12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        12.2.1. By Country
            12.2.1.1. Poland
            12.2.1.2. Russia
            12.2.1.3. Czech Republic
            12.2.1.4. Romania
            12.2.1.5. Rest of Eastern Europe
        12.2.2. By Product
        12.2.3. By End User
        12.2.4. By Indication
    12.3. Market Attractiveness Analysis
        12.3.1. By Country
        12.3.2. By Product
        12.3.3. By End User
        12.3.4. By Indication
    12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        13.2.1. By Country
            13.2.1.1. India
            13.2.1.2. Bangladesh
            13.2.1.3. Australia
            13.2.1.4. New Zealand
            13.2.1.5. Rest of South Asia and Pacific
        13.2.2. By Product
        13.2.3. By End User
        13.2.4. By Indication
    13.3. Market Attractiveness Analysis
        13.3.1. By Country
        13.3.2. By Product
        13.3.3. By End User
        13.3.4. By Indication
    13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        14.2.1. By Country
            14.2.1.1. China
            14.2.1.2. Japan
            14.2.1.3. South Korea
        14.2.2. By Product
        14.2.3. By End User
        14.2.4. By Indication
    14.3. Market Attractiveness Analysis
        14.3.1. By Country
        14.3.2. By Product
        14.3.3. By End User
        14.3.4. By Indication
    14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        15.2.1. By Country
            15.2.1.1. GCC Countries
            15.2.1.2. South Africa
            15.2.1.3. Israel
            15.2.1.4. Rest of MEA
        15.2.2. By Product
        15.2.3. By End User
        15.2.4. By Indication
    15.3. Market Attractiveness Analysis
        15.3.1. By Country
        15.3.2. By Product
        15.3.3. By End User
        15.3.4. By Indication
    15.4. Key Takeaways
16. Key Countries Market Analysis
    16.1. USA
        16.1.1. Pricing Analysis
        16.1.2. Market Share Analysis, 2022
            16.1.2.1. By Product
            16.1.2.2. By End User
            16.1.2.3. By Indication
    16.2. Canada
        16.2.1. Pricing Analysis
        16.2.2. Market Share Analysis, 2022
            16.2.2.1. By Product
            16.2.2.2. By End User
            16.2.2.3. By Indication
    16.3. Brazil
        16.3.1. Pricing Analysis
        16.3.2. Market Share Analysis, 2022
            16.3.2.1. By Product
            16.3.2.2. By End User
            16.3.2.3. By Indication
    16.4. Mexico
        16.4.1. Pricing Analysis
        16.4.2. Market Share Analysis, 2022
            16.4.2.1. By Product
            16.4.2.2. By End User
            16.4.2.3. By Indication
    16.5. Germany
        16.5.1. Pricing Analysis
        16.5.2. Market Share Analysis, 2022
            16.5.2.1. By Product
            16.5.2.2. By End User
            16.5.2.3. By Indication
    16.6. U.K.
        16.6.1. Pricing Analysis
        16.6.2. Market Share Analysis, 2022
            16.6.2.1. By Product
            16.6.2.2. By End User
            16.6.2.3. By Indication
    16.7. France
        16.7.1. Pricing Analysis
        16.7.2. Market Share Analysis, 2022
            16.7.2.1. By Product
            16.7.2.2. By End User
            16.7.2.3. By Indication
    16.8. Spain
        16.8.1. Pricing Analysis
        16.8.2. Market Share Analysis, 2022
            16.8.2.1. By Product
            16.8.2.2. By End User
            16.8.2.3. By Indication
    16.9. Italy
        16.9.1. Pricing Analysis
        16.9.2. Market Share Analysis, 2022
            16.9.2.1. By Product
            16.9.2.2. By End User
            16.9.2.3. By Indication
    16.10. Poland
        16.10.1. Pricing Analysis
        16.10.2. Market Share Analysis, 2022
            16.10.2.1. By Product
            16.10.2.2. By End User
            16.10.2.3. By Indication
    16.11. Russia
        16.11.1. Pricing Analysis
        16.11.2. Market Share Analysis, 2022
            16.11.2.1. By Product
            16.11.2.2. By End User
            16.11.2.3. By Indication
    16.12. Czech Republic
        16.12.1. Pricing Analysis
        16.12.2. Market Share Analysis, 2022
            16.12.2.1. By Product
            16.12.2.2. By End User
            16.12.2.3. By Indication
    16.13. Romania
        16.13.1. Pricing Analysis
        16.13.2. Market Share Analysis, 2022
            16.13.2.1. By Product
            16.13.2.2. By End User
            16.13.2.3. By Indication
    16.14. India
        16.14.1. Pricing Analysis
        16.14.2. Market Share Analysis, 2022
            16.14.2.1. By Product
            16.14.2.2. By End User
            16.14.2.3. By Indication
    16.15. Bangladesh
        16.15.1. Pricing Analysis
        16.15.2. Market Share Analysis, 2022
            16.15.2.1. By Product
            16.15.2.2. By End User
            16.15.2.3. By Indication
    16.16. Australia
        16.16.1. Pricing Analysis
        16.16.2. Market Share Analysis, 2022
            16.16.2.1. By Product
            16.16.2.2. By End User
            16.16.2.3. By Indication
    16.17. New Zealand
        16.17.1. Pricing Analysis
        16.17.2. Market Share Analysis, 2022
            16.17.2.1. By Product
            16.17.2.2. By End User
            16.17.2.3. By Indication
    16.18. China
        16.18.1. Pricing Analysis
        16.18.2. Market Share Analysis, 2022
            16.18.2.1. By Product
            16.18.2.2. By End User
            16.18.2.3. By Indication
    16.19. Japan
        16.19.1. Pricing Analysis
        16.19.2. Market Share Analysis, 2022
            16.19.2.1. By Product
            16.19.2.2. By End User
            16.19.2.3. By Indication
    16.20. South Korea
        16.20.1. Pricing Analysis
        16.20.2. Market Share Analysis, 2022
            16.20.2.1. By Product
            16.20.2.2. By End User
            16.20.2.3. By Indication
    16.21. GCC Countries
        16.21.1. Pricing Analysis
        16.21.2. Market Share Analysis, 2022
            16.21.2.1. By Product
            16.21.2.2. By End User
            16.21.2.3. By Indication
    16.22. South Africa
        16.22.1. Pricing Analysis
        16.22.2. Market Share Analysis, 2022
            16.22.2.1. By Product
            16.22.2.2. By End User
            16.22.2.3. By Indication
    16.23. Israel
        16.23.1. Pricing Analysis
        16.23.2. Market Share Analysis, 2022
            16.23.2.1. By Product
            16.23.2.2. By End User
            16.23.2.3. By Indication
17. Market Structure Analysis
    17.1. Competition Dashboard
    17.2. Competition Benchmarking
    17.3. Market Share Analysis of Top Players
        17.3.1. By Regional
        17.3.2. By Product
        17.3.3. By End User
        17.3.4. By Indication
18. Competition Analysis
    18.1. Competition Deep Dive
        18.1.1. Zimmer, Inc.
            18.1.1.1. Overview
            18.1.1.2. Product Portfolio
            18.1.1.3. Profitability by Market Segments
            18.1.1.4. Sales Footprint
            18.1.1.5. Strategy Overview
                18.1.1.5.1. Marketing Strategy
                18.1.1.5.2. Product Strategy
                18.1.1.5.3. Channel Strategy
        18.1.2. Stryker Corporation
            18.1.2.1. Overview
            18.1.2.2. Product Portfolio
            18.1.2.3. Profitability by Market Segments
            18.1.2.4. Sales Footprint
            18.1.2.5. Strategy Overview
                18.1.2.5.1. Marketing Strategy
                18.1.2.5.2. Product Strategy
                18.1.2.5.3. Channel Strategy
        18.1.3. DePuy Synthes
            18.1.3.1. Overview
            18.1.3.2. Product Portfolio
            18.1.3.3. Profitability by Market Segments
            18.1.3.4. Sales Footprint
            18.1.3.5. Strategy Overview
                18.1.3.5.1. Marketing Strategy
                18.1.3.5.2. Product Strategy
                18.1.3.5.3. Channel Strategy
        18.1.4. Smith & Nephew
            18.1.4.1. Overview
            18.1.4.2. Product Portfolio
            18.1.4.3. Profitability by Market Segments
            18.1.4.4. Sales Footprint
            18.1.4.5. Strategy Overview
                18.1.4.5.1. Marketing Strategy
                18.1.4.5.2. Product Strategy
                18.1.4.5.3. Channel Strategy
        18.1.5. Corin
            18.1.5.1. Overview
            18.1.5.2. Product Portfolio
            18.1.5.3. Profitability by Market Segments
            18.1.5.4. Sales Footprint
            18.1.5.5. Strategy Overview
                18.1.5.5.1. Marketing Strategy
                18.1.5.5.2. Product Strategy
                18.1.5.5.3. Channel Strategy
        18.1.6. Value (US$ Million) & Volume (Units)ed Orthopedic Corporation
            18.1.6.1. Overview
            18.1.6.2. Product Portfolio
            18.1.6.3. Profitability by Market Segments
            18.1.6.4. Sales Footprint
            18.1.6.5. Strategy Overview
                18.1.6.5.1. Marketing Strategy
                18.1.6.5.2. Product Strategy
                18.1.6.5.3. Channel Strategy
        18.1.7. Arthrex Inc.
            18.1.7.1. Overview
            18.1.7.2. Product Portfolio
            18.1.7.3. Profitability by Market Segments
            18.1.7.4. Sales Footprint
            18.1.7.5. Strategy Overview
                18.1.7.5.1. Marketing Strategy
                18.1.7.5.2. Product Strategy
                18.1.7.5.3. Channel Strategy
        18.1.8. Exactech Inc.
            18.1.8.1. Overview
            18.1.8.2. Product Portfolio
            18.1.8.3. Profitability by Market Segments
            18.1.8.4. Sales Footprint
            18.1.8.5. Strategy Overview
                18.1.8.5.1. Marketing Strategy
                18.1.8.5.2. Product Strategy
                18.1.8.5.3. Channel Strategy
        18.1.9. DJO Global
            18.1.9.1. Overview
            18.1.9.2. Product Portfolio
            18.1.9.3. Profitability by Market Segments
            18.1.9.4. Sales Footprint
            18.1.9.5. Strategy Overview
                18.1.9.5.1. Marketing Strategy
                18.1.9.5.2. Product Strategy
                18.1.9.5.3. Channel Strategy
        18.1.10. Japan Medical Dynamic Marketing
            18.1.10.1. Overview
            18.1.10.2. Product Portfolio
            18.1.10.3. Profitability by Market Segments
            18.1.10.4. Sales Footprint
            18.1.10.5. Strategy Overview
                18.1.10.5.1. Marketing Strategy
                18.1.10.5.2. Product Strategy
                18.1.10.5.3. Channel Strategy
        18.1.11. Tornier Inc.
            18.1.11.1. Overview
            18.1.11.2. Product Portfolio
            18.1.11.3. Profitability by Market Segments
            18.1.11.4. Sales Footprint
            18.1.11.5. Strategy Overview
                18.1.11.5.1. Marketing Strategy
                18.1.11.5.2. Product Strategy
                18.1.11.5.3. Channel Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Recommendations

Healthcare

Knee Replacement Market

March 2024

REP-GB-864

342 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Knee Reconstruction Devices Market

Schedule a Call